Literature DB >> 25527076

Foxp1/2/4 regulate endochondral ossification as a suppresser complex.

Haixia Zhao1, Wenrong Zhou1, Zhengju Yao1, Yong Wan1, Jingjing Cao1, Lingling Zhang1, Jianzhi Zhao1, Hanjun Li1, Rujiang Zhou1, Baojie Li1, Gang Wei2, Zhenlin Zhang3, Catherine A French4, Joseph D Dekker5, Yingzi Yang6, Simon E Fisher7, Haley O Tucker5, Xizhi Guo8.   

Abstract

Osteoblast induction and differentiation in developing long bones is dynamically controlled by the opposing action of transcriptional activators and repressors. In contrast to the long list of activators that have been discovered over past decades, the network of repressors is not well-defined. Here we identify the expression of Foxp1/2/4 proteins, comprised of Forkhead-box (Fox) transcription factors of the Foxp subfamily, in both perichondrial skeletal progenitors and proliferating chondrocytes during endochondral ossification. Mice carrying loss-of-function and gain-of-function Foxp mutations had gross defects in appendicular skeleton formation. At the cellular level, over-expression of Foxp1/2/4 in chondroctyes abrogated osteoblast formation and chondrocyte hypertrophy. Conversely, single or compound deficiency of Foxp1/2/4 in skeletal progenitors or chondrocytes resulted in premature osteoblast differentiation in the perichondrium, coupled with impaired proliferation, survival, and hypertrophy of chondrocytes in the growth plate. Foxp1/2/4 and Runx2 proteins interacted in vitro and in vivo, and Foxp1/2/4 repressed Runx2 transactivation function in heterologous cells. This study establishes Foxp1/2/4 proteins as coordinators of osteogenesis and chondrocyte hypertrophy in developing long bones and suggests that a novel transcriptional repressor network involving Foxp1/2/4 may regulate Runx2 during endochondral ossification.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Endochondral ossification; Foxp1; Foxp2; Foxp4; Osteoblast; Transcriptional repressor

Mesh:

Substances:

Year:  2014        PMID: 25527076      PMCID: PMC4342236          DOI: 10.1016/j.ydbio.2014.12.007

Source DB:  PubMed          Journal:  Dev Biol        ISSN: 0012-1606            Impact factor:   3.582


  58 in total

1.  Runx2 inhibits chondrocyte proliferation and hypertrophy through its expression in the perichondrium.

Authors:  Eiichi Hinoi; Peter Bialek; You-Tzung Chen; Marie-Therese Rached; Yoram Groner; Richard R Behringer; David M Ornitz; Gerard Karsenty
Journal:  Genes Dev       Date:  2006-10-18       Impact factor: 11.361

Review 2.  Transcriptional networks controlling skeletal development.

Authors:  Christine Hartmann
Journal:  Curr Opin Genet Dev       Date:  2009-10-14       Impact factor: 5.578

3.  Targeted disruption of Cbfa1 results in a complete lack of bone formation owing to maturational arrest of osteoblasts.

Authors:  T Komori; H Yagi; S Nomura; A Yamaguchi; K Sasaki; K Deguchi; Y Shimizu; R T Bronson; Y H Gao; M Inada; M Sato; R Okamoto; Y Kitamura; S Yoshiki; T Kishimoto
Journal:  Cell       Date:  1997-05-30       Impact factor: 41.582

Review 4.  Cancer genetics and genomics of human FOX family genes.

Authors:  Masuko Katoh; Maki Igarashi; Hirokazu Fukuda; Hitoshi Nakagama; Masaru Katoh
Journal:  Cancer Lett       Date:  2012-09-27       Impact factor: 8.679

Review 5.  Unraveling the role of FoxOs in bone--insights from mouse models.

Authors:  Maria Almeida
Journal:  Bone       Date:  2011-06-01       Impact factor: 4.398

Review 6.  Development of the endochondral skeleton.

Authors:  Fanxin Long; David M Ornitz
Journal:  Cold Spring Harb Perspect Biol       Date:  2013-01-01       Impact factor: 10.005

7.  HDAC4 represses matrix metalloproteinase-13 transcription in osteoblastic cells, and parathyroid hormone controls this repression.

Authors:  Emi Shimizu; Nagarajan Selvamurugan; Jennifer J Westendorf; Eric N Olson; Nicola C Partridge
Journal:  J Biol Chem       Date:  2010-01-22       Impact factor: 5.157

8.  An analysis of skeletal development in osteoblast-specific and chondrocyte-specific runt-related transcription factor-2 (Runx2) knockout mice.

Authors:  Takeshi Takarada; Eiichi Hinoi; Ryota Nakazato; Hiroki Ochi; Cheng Xu; Azusa Tsuchikane; Shu Takeda; Gerard Karsenty; Takaya Abe; Hiroshi Kiyonari; Yukio Yoneda
Journal:  J Bone Miner Res       Date:  2013-10       Impact factor: 6.741

9.  Expression of Cre Recombinase in the developing mouse limb bud driven by a Prxl enhancer.

Authors:  Malcolm Logan; James F Martin; Andras Nagy; Corrinne Lobe; Eric N Olson; Clifford J Tabin
Journal:  Genesis       Date:  2002-06       Impact factor: 2.487

10.  A twist code determines the onset of osteoblast differentiation.

Authors:  Peter Bialek; Britt Kern; Xiangli Yang; Marijke Schrock; Drazen Sosic; Nancy Hong; Hua Wu; Kai Yu; David M Ornitz; Eric N Olson; Monica J Justice; Gerard Karsenty
Journal:  Dev Cell       Date:  2004-03       Impact factor: 12.270

View more
  32 in total

1.  Identification of differentially methylated regions in new genes associated with knee osteoarthritis.

Authors:  Carolina A Bonin; Eric A Lewallen; Saurabh Baheti; Elizabeth W Bradley; Michael J Stuart; Daniel J Berry; Andre J van Wijnen; Jennifer J Westendorf
Journal:  Gene       Date:  2015-10-17       Impact factor: 3.688

2.  PITX1 promotes chondrogenesis and myogenesis in mouse hindlimbs through conserved regulatory targets.

Authors:  Jialiang S Wang; Carlos R Infante; Sungdae Park; Douglas B Menke
Journal:  Dev Biol       Date:  2017-12-20       Impact factor: 3.582

3.  FOXP1 drives osteosarcoma development by repressing P21 and RB transcription downstream of P53.

Authors:  Hanjun Li; Xiuguo Han; Shengbing Yang; Yongjie Wang; Yang Dong; Tingting Tang
Journal:  Oncogene       Date:  2021-03-14       Impact factor: 9.867

4.  FOXP1 controls mesenchymal stem cell commitment and senescence during skeletal aging.

Authors:  Hanjun Li; Pei Liu; Shuqin Xu; Yinghua Li; Joseph D Dekker; Baojie Li; Ying Fan; Zhenlin Zhang; Yang Hong; Gong Yang; Tingting Tang; Yongxin Ren; Haley O Tucker; Zhengju Yao; Xizhi Guo
Journal:  J Clin Invest       Date:  2017-02-27       Impact factor: 14.808

5.  SOX9 is dispensable for the initiation of epigenetic remodeling and the activation of marker genes at the onset of chondrogenesis.

Authors:  Chia-Feng Liu; Marco Angelozzi; Abdul Haseeb; Véronique Lefebvre
Journal:  Development       Date:  2018-07-18       Impact factor: 6.868

Review 6.  Transcriptional control of chondrocyte specification and differentiation.

Authors:  Chia-Feng Liu; William E Samsa; Guang Zhou; Véronique Lefebvre
Journal:  Semin Cell Dev Biol       Date:  2016-10-19       Impact factor: 7.727

7.  Expression of forkhead box transcription factor genes Foxp1 and Foxp2 during jaw development.

Authors:  Jeffry M Cesario; Asma A Almaidhan; Juhee Jeong
Journal:  Gene Expr Patterns       Date:  2016-03-09       Impact factor: 1.224

8.  Evolutionary Selection and Constraint on Human Knee Chondrocyte Regulation Impacts Osteoarthritis Risk.

Authors:  Daniel Richard; Zun Liu; Jiaxue Cao; Ata M Kiapour; Jessica Willen; Siddharth Yarlagadda; Evelyn Jagoda; Vijaya B Kolachalama; Jakob T Sieker; Gary H Chang; Pushpanathan Muthuirulan; Mariel Young; Anand Masson; Johannes Konrad; Shayan Hosseinzadeh; David E Maridas; Vicki Rosen; Roman Krawetz; Neil Roach; Terence D Capellini
Journal:  Cell       Date:  2020-03-26       Impact factor: 41.582

Review 9.  SOX9 in cartilage development and disease.

Authors:  Véronique Lefebvre; Marco Angelozzi; Abdul Haseeb
Journal:  Curr Opin Cell Biol       Date:  2019-08-02       Impact factor: 8.382

10.  Foxp2 regulates anatomical features that may be relevant for vocal behaviors and bipedal locomotion.

Authors:  Shuqin Xu; Pei Liu; Yuanxing Chen; Yi Chen; Wei Zhang; Haixia Zhao; Yiwei Cao; Fuhua Wang; Nana Jiang; Shifeng Lin; Baojie Li; Zhenlin Zhang; Zhanying Wei; Ying Fan; Yunyun Jin; Lin He; Rujiang Zhou; Joseph D Dekker; Haley O Tucker; Simon E Fisher; Zhengju Yao; Quansheng Liu; Xuechun Xia; Xizhi Guo
Journal:  Proc Natl Acad Sci U S A       Date:  2018-08-13       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.